Department of Computer Science, 34933Chungbuk National University, Cheongju, South Korea.
Health Informatics J. 2022 Apr-Jun;28(2):14604582221101529. doi: 10.1177/14604582221101529.
Heart failure is a clinical syndrome that occurs when the heart is too weak or stiff and cannot pump enough blood that our body needs. It is one of the most expensive diseases due to frequent hospitalizations and emergency room visits. Reducing unnecessary rehospitalizations is also an important and challenging task that has the potential of saving healthcare costs, enabling discharge planning, and identifying patients at high risk. Therefore, this paper proposes a deep learning-based prediction model of heart failure rehospitalization during 6, 12, 24-month follow-ups after hospital discharge in patients with acute myocardial infarction (AMI). We used the Korea Acute Myocardial Infarction-National Institutes of Health (KAMIR-NIH) registry which included 13,104 patient records and 551 features. The proposed deep learning-based rehospitalization prediction model outperformed traditional machine learning algorithms such as logistic regression, support vector machine, AdaBoost, gradient boosting machine, and random forest. The performance of the proposed model was accuracy, the area under the curve, precision, recall, specificity, and F1 score of 99.37%, 99.90%, 96.86%, 98.61%, 99.49%, and 97.73%, respectively. This study showed the potential of a deep learning-based model for cardiology, which can be used for decision-making and medical diagnosis tool of heart failure rehospitalization in patients with AMI.
心力衰竭是一种临床综合征,当心脏过于虚弱或僵硬,无法泵出足够的血液来满足身体的需要时就会发生。由于频繁住院和急诊就诊,它是最昂贵的疾病之一。减少不必要的再住院也是一项重要且具有挑战性的任务,有潜力节省医疗保健成本、进行出院计划,并识别高风险患者。因此,本文提出了一种基于深度学习的急性心肌梗死(AMI)患者出院后 6、12、24 个月随访期间心力衰竭再住院预测模型。我们使用了包括 13104 例患者记录和 551 个特征的韩国急性心肌梗死-美国国立卫生研究院(KAMIR-NIH)注册中心。提出的基于深度学习的再住院预测模型优于传统的机器学习算法,如逻辑回归、支持向量机、AdaBoost、梯度提升机和随机森林。该模型的性能表现为 99.37%的准确率、99.90%的曲线下面积、96.86%的精确率、98.61%的召回率、99.49%的特异性和 97.73%的 F1 分数。这项研究表明,基于深度学习的模型在心脏病学中有应用潜力,可用于 AMI 患者心力衰竭再住院的决策和医疗诊断工具。